[Federal Register Volume 78, Number 5 (Tuesday, January 8, 2013)]
[Notices]
[Pages 1216-1217]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-00089]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: January 24, 2013.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will
discuss Biosafety measures for research with highly pathogenic avian
influenza H5N1 strains that have the potential to be transmissible
through respiratory droplets and related data management activities.
Please check the meeting agenda at OBA Meetings Page (available at
the following URL: http://oba.od.nih.gov/rdna_rac/rac_meetings.html) for more information.
Place: National Institutes of Health, Building 45, Lower Level,
Conference Room C1-C2, 45 Center Drive, Rockville, MD 20892.
Contact Person: Chezelle George, Office of Biotechnology
Activities, Office of Science Policy/OD, National Institutes of
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-
9838, georgec@od.nih.gov.
Information is also available on the Institute's/Center's home
page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any
additional information for the meeting will be posted when
available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11,
[[Page 1217]]
1980) requires a statement concerning the official government
programs contained in the Catalog of Federal Domestic Assistance.
Normally NIH lists in its announcements the number and title of
affected individual programs for the guidance of the public. Because
the guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected to follow the NIH Guidelines. In
lieu of the individual program listing, NIH invites readers to
direct questions to the information address above about whether
individual programs listed in the Catalog of Federal Domestic
Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
OBA will offer those members of the public viewing the meeting via
webcast (see link on OBA Meetings Page) the opportunity to submit
comments to be read during the scheduled public comment periods.
Individuals wishing to submit comments should use the comment form,
which will accommodate comments up to 1500 characters, and will be
available on the OBA Meetings Page during the meeting. Please submit
your comment prior to the start of the public comment period. Please
limit your comment to a statement that can be read in one to two
minutes. Please include your name and affiliation with your comment.
OBA will read comments into the record during the public comment
periods that are specified on the agenda. Please note, while every
effort is made to keep the meeting discussions to the times stated on
the agenda, it is not unusual for the meeting to run ahead or behind
schedule due to changes in the time needed to review a protocol. It is
advisable to monitor the webcast to determine when public comments will
be read. Comments submitted electronically will follow any comments by
individuals attending the meeting in person. Comments will be read in
the order received and your name and affiliation will be read with the
comment. Please note OBA may not be able to read every comment received
in the time allotted for public comment. Comments not read will become
part of the public record.
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
Dated: January 3, 2012.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-00089 Filed 1-7-13; 8:45 am]
BILLING CODE 4140-01-P